News
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec reports Q1 2024 results and provides corporate update
Evotec SE reports Q1 2024 financial results and corporate update, outlines growth in Just - Evotec Biologics and challenges in transactional business. New CEO and CPO appointments. Group revenues expected to grow double-digit in FY 2024 -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Bayer and Evotec collaborate to advance precision cardiology
Bayer and Evotec collaborate to advance precision cardiology, focusing on innovative therapies for cardiovascular diseases. The strategic alliance aims to leverage human induced pluripotent stem cells for novel targets -